Merck Profit Rises on Strong Keytruda Demand

Published 1 week ago Positive
Merck Profit Rises on Strong Keytruda Demand
Auto
Merck reported higher third-quarter profit and boosted its full-year outlook, as demand for its flagship Keytruda cancer drug continues to rise.

Continue Reading

View Comments

More News

Did Jacobs Solutions’ (J) Mukaab Win in Riyadh Redefine Its Global Infrastructure Ambitions?

11 minutes ago Positive

TVRD SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics

12 minutes ago Positive

Why Meta Is the Stock to Watch This Earnings Season

17 minutes ago Positive

Notable healthcare headlines for the week: Pfizer, Novo Nordisk, Moderna in focus

25 minutes ago Positive

NJDCY SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nidec

26 minutes ago Positive